【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of ADCs
• Antibodies
• Evolution of mAb therapeutics
• Conjugated mAbs
• History
• Key components in ADCs
• Next-generation ADCs
• Advantages
• Challenges
• Outsourcing of ADCs manufacturing
• Emergence of ADCs
• Current marketed ADCs
PART 06: Pipeline portfolio
• Information on pipeline candidates
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by MOA
• IgG1 antibodies
• HER2 antibodies
PART 09: Market segmentation by technologies used in ADCs
• Seattle Genetics (SGEN) technology
• ImmunoGen (IMGN) technology
• Immunomedics (IMMU) technology
PART 10: Geographical segmentation
PART 11: Market drivers
• Robust late-stage pipeline
• Rising prevalence of cancers
• Increase in demand for antibody conjugates
• Reimbursement policies
PART 12: Impact of drivers
PART 13: Market challenges
• High developmental costs
• Stringent regulations
• Risk of side effects
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Strategic alliances
• Increased outsourcing of drug development
• Emergence of targeted and combination therapies
PART 16: Vendor landscape
• Competitive scenario
• Key news
• F. Hoffmann-La Roche
• Seattle Genetics
• Takeda Pharmaceuticals
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Comparison of small molecule and mAbs
Exhibit 03: Preparation of mAbs
Exhibit 04: Timeline of ADCs
Exhibit 05: Key components
Exhibit 06: Components of next-generation ADCs
Exhibit 07: Advantages of ADCs
Exhibit 08: Emergence of ADCs
Exhibit 09: Marked ADCs products
Exhibit 10: Pipeline portfolio of ADCs
Exhibit 11: Pipeline share of ADCs
Exhibit 12: Market share of ADCs in clinical development
Exhibit 13: Few target antigens for ADCs in clinical development
Exhibit 14: Top five companies share in ADC pipeline
Exhibit 15: Global ADCs market 2015-2020 ($ billions)
Exhibit 16: Five forces analysis
Exhibit 17: Global ADCs market segmentation by MOA
Exhibit 18: Components in IMGN technology
Exhibit 19: Share of ADCs technologies
Exhibit 20: Global ADCs market by geography 2015
Exhibit 21: ADCs market in Americas 2015
Exhibit 22: ADCs market in Europe 2015
Exhibit 23: ADCs market in Japan 2015
Exhibit 24: Global incidence of cancer 2015 and 2020
Exhibit 25: Impact of drivers
Exhibit 26: Impact of drivers and challenges
Exhibit 27: F. Hoffmann-La Roche: Pharmaceutical division segmentation by revenue 2015
Exhibit 28: F. Hoffmann-La Roche: ADC segmentation by revenue 2015
Exhibit 29: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2015 ($ millions)
Exhibit 30: F. Hoffmann-La Roche: Geographical segmentation of Kadcyla by revenue 2015
Exhibit 31: F. Hoffmann-La Roche: YoY revenue and growth rate of Kadcyla in US 2013-2015 ($ millions)
Exhibit 32: F. Hoffmann-La Roche: YoY revenue and growth rate of Kadcyla in Europe 2014 and 2015 ($ millions)
Exhibit 33: F. Hoffmann-La Roche: YoY revenue and growth rate of Kadcyla in Japan 2014-2015 ($ millions)
Exhibit 34: F. Hoffmann-La Roche: YoY revenue and growth rate of Kadcyla in ROW 2013-2015 ($ millions)
Exhibit 35: F. Hoffmann La-Roche: Kadcyla pipeline products
Exhibit 36: F. Hoffmann La-Roche: Key takeaways
Exhibit 37: Seattle Genetics: YoY revenue and growth rate of ADCETRIS in US and Canada ($ millions)
Exhibit 38: Seattle Genetics: ADCETRIS developmental pipeline
Exhibit 39: Seattle Genetics: ADCs pipeline and seven clinical trial programs
Exhibit 40: Seattle Genetics: ADC collaborations
Exhibit 41: Seattle Genetics: Key takeaways
Exhibit 42: Takeda: Business segmentation by revenue 2015
Exhibit 43: Takeda Pharmaceuticals: Geographical segmentation by revenue 2015
Exhibit 44: Takeda Pharmaceuticals: YoY growth and revenue generated from ADCETRIS (except US and Canada) 2013-2015 ($ millions)
Exhibit 45: Takeda Pharmaceuticals: Key takeaways
【レポート販売概要】
■ タイトル：抗体薬物複合体（ADC）の世界市場：シアトルジェネティクス技術、ImmunoGen技術、Immunomedics技術■ 英文：Global Antibody Conjugates Drugs Market 2016-2020
■ 発行日：2016年3月31日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8911
■ 調査対象地域：グローバル
- グローバル・リテールバンク市場における企業のICT投資動向Summary This report presents the findings from a survey of 136 retail banks regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how retail banks currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting. Key Findings • Kable’s survey shows that retail …
- 世界のデータセンター・セキュリティー市場動向（2012-2016）TechNavio's analysts forecast the Global Data Center Security market to grow at a CAGR of 10.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need to protect virtualized equipment. The Global Data Center Security market has also been witnessing the growing adoption of disaster recovery solutions. However, the increasing cost of procurin …
- 放射線検出用素材の世界市場2015-2022Growth in the demand for radiation detection, especially for homeland security and medical applications, is driving the need for radiation detection materials that can provide sufficient performance at the right price. Increased interest in mobile radiation detection for security and military applications places more emphasis on materials that can reliably distinguish between naturally occurring a …
- 食道炎(Esophagitis)：世界の治験レビュー（2015年上半期版）Esophagitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Esophagitis Global Clinical Trials Review, H1, 2015" provides data on the Esophagitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophagitis. It includes an overview of the trial numbers and their recruitment status as per the site of …
- Diabetes Therapeutics Market in India to 2018 – Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive GrowthDiabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth Summary GBI Research, the leading business intelligence provider, has released its latest research “Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth”, which prov …
- グローバルにおける統合失調症（Schizophrenia）治療薬市場及びパイプライン分析Schizophrenia is defined as a disorder of the brain which impacts the way in which a person acts, thinks, and sees the world. It has been observed that the patients suffering from schizophrenia generally tend to have an altered perception of reality, which reveals a significant diversion from the reality. In most cases, schizophrenia is diagnosed among people in the late teens or early adulthood. …
- 沿岸監視の世界市場展望2017-2026According to Stratistics MRC, the Global Coastal Surveillance market accounted for $30.62 billion in 2017 and is expected to reach $48.73 billion by 2026 growing at a CAGR of 5.3% during the forecast period. Growing demand for cloud-based security solutions, increase in the frequency and sophistication of cyber frauds and attacks and emergence of big data analytics are some key factors boosting th …
- 木質燃料の世界市場2019-2023About this market The The regulations for GHG emissions and the use of bioenergy in heating systems will trigger the wood fuels market growth during the forecast period. The US EPA has been developing common-sense regulatory initiatives for reducing emissions and improving efficiency in emission reduction. In addition, the US EPA has also been supporting the use of CHP due to its cost-effective re …
- 輸送コンテナセキュリティ及び追跡の世界市場About Container Security and Tracking Container security and tracking refers to software and hardware solutions that offer end-to-end visibility and monitoring of shipping containers to track the precise location and status against terrorist attacks and cargo theft. A rise in terrorist attacks, arms smuggling, and drug trafficking through seaborne trade globally has increased the demand for contai …
- グローバルの太陽光発電市場2016：発電能力、生産、投資動向、制度、企業Solar Photovoltaic (PV) Market, Update 2016 - Global Market Size, Market Share, Average Price, Regulations and Key Country Analysis to 2025 Summary “Solar Photovoltaic (PV) Market, Update 2016 - Global Market Size, Market Share, Average Price, Regulations and Key Country Analysis to 2025”, the latest report from industry research specialist GlobalData, offers comprehensive information and analysis …
- 世界の大静脈フィルター市場動向（2012-2016）TechNavio's analysts forecast the Global Vena Cava Filters market to grow at a CAGR of 11.37 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased sale of retrievable filters. The Global Vena Cava Filters market has also been witnessing an increased number of mergers and acquisitions. However, the increasing number of FDA warnings could pose …
- 北米のガス処理産業Gas Processing Industry Outlook in North America to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants Summary "Gas Processing Industry Outlook in North America to 2020 - Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Processing Plants" is a comprehensive report on gas processing industry in North Amer …
- 自動倉庫システム（ASRS）の世界市場予測（～2022）The automated storage and retrieval system (ASRS) market is expected to grow from USD 5.19 Billion in 2015 to reach USD 8.43 Billion by 2022, at a CAGR of 7.1% between 2016 and 2022. The ASRS market is currently witnessing a growing demand from automotive and food & beverages industries as ASRS is highly recommended in these industries for storing and retrieving goods from the inventory on a real- …
- 2014 Assessments of Leading Infectious Disease Market Players–Insightful Profiles of Major Suppliers and Emerging Market EntrantsThis new report from Venture Planning Group provides strategic assessments of major suppliers of infectious deisease instuments and reagants, as well as emerging market entrants. The report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-ho …
- 免疫療法治療薬の世界市場予測（～2021）：薬種類別（成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ）、治療分野別、需要先別、地域別The global immunotherapy drugs market is projected to reach USD 201.52 Billion by 2021 from USD 108.41 Billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increasing adoption of targeted therapies with fewer side effects, quicker drug approval processes, and high prevalence rate of lifestyle diseases are major growth drivers of this market. On the other hand, th …
